Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium

Mise à jour : Il y a 4 ans
Référence : NCT01109056

Femme et Homme

Extrait

This study will evaluate the safety and efficacy of Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) in patients with primary pterygium (abnormal growth on surface of eye).


Critère d'inclusion

  • Pterygium

Liens